LENSKART vs MOLBIO: Stock Comparison
Head-to-head financial and trading comparison between Lenskart Solutions Limited (LENSKART) and Molbio Diagnostics Limited (MOLBIO) in the Cross-Sector Peers sector.
LENSKART
NSE: LENSKARTMOLBIO
NSE: MOLBIOKey Metrics Comparison Table
| Metric | LENSKART | MOLBIO | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹677.65 | ₹1,438.60 | — |
| 1-Year Price Return | +27.21% | +38.1% | MOLBIO (10.89% higher) |
| 52-Week High | ₹707.20 | ₹1,544.70 | — |
| 52-Week Low | ₹469.25 | ₹1,036.65 | — |
| 30-Day Annualized Volatility | 31.66% | 95.93% | LENSKART (Steadier) |
| 30-Day Average Daily Volume | 11,089,994 | 3,210,458 | LENSKART (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between LENSKART and MOLBIO, which stock gave better returns over the last year?
MOLBIO has outperformed LENSKART over the past 12 months with a gain of 38.1% compared to 27.21%.
Which stock is less volatile: LENSKART or MOLBIO?
LENSKART demonstrated lower price volatility (31.66% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of LENSKART vs MOLBIO?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are LENSKART and MOLBIO direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.